Skip to main content
. 2020 Aug 4;12(8):2329. doi: 10.3390/nu12082329

Table 3.

A summary of the effects of linoleic acid consumption on lipid risk markers for cardiovascular disease in healthy individuals (ordered by date of publication).

Author (Year) Study Subjects Age Duration Treatment Linoleic Acid Results
Bronsgeest-Schoute et al. (1979) [39] Randomized crossover 41 total
24 males
17 females
19–35 years
mean, 22.1 years
4 weeks 14 to 15% E LA (25 to 50 g/d), with at least 600 mg C for 2 wk, and 2 wk of less than 200 mg C. ↑serum C
(high C diet compared with low C diet)
↔TG
Sanders et al. (1983) [41] Randomized double-blinded crossover 10 total
6 males
4 females
22–35 years 4 weeks 10 g/d fish oil supplement (1.7 g EPA and 1.2 g DHA) or vegetable oil (3.4 g/d LA) for 2 wk. ↔total C, ↑TG, ↓HDL-C
(compared with fish oil)
Iacono et al. (1991) [33] Randomized crossover 11 males 44–62 years
mean, 53.6 years
100 days Baseline period of 20 d (typical US diet, but meeting RDAs), followed by a lower LA diet (3.8% E; 16 g/100 g dietary fat) and a higher LA diet (10.8% E; 37.8 g/100 g dietary fat) for 40 d. ↓total C, ↓LDL-C, ↓apoB
(both diets compared to baseline; 10.8% E LA diet had further decreases)
↔HDL-C, ↔TG, ↑apoA1
(both diets compared to baseline)
Zock et al. (1992) [34] Randomized
multiple crossover
56 total
26 males
30 females
Males: 19–48 years mean, 25 years
Females: 18–49 years mean, 24 years
9 weeks Three diets were followed for 3 wk: high in LA (12% E LA), high in SA (11.8% E SA; 3.9% E LA), and high elaidic acid (7.7% E elaidic acid; 3.8% E LA). ↓total C, ↓LDL-C
↑HDL-C, ↑HDL:LDL ratio ↓TG
(compared to SA diet)
↓apoB, ↑apoA1:apoB ratio
Mensink et al. (1992) [48] Intervention trial 58 total
27 males
31 females
Young (specific ages not stated) 53 days 17 d on a diet high in SFA (19.3% E; primarily PA and SA), followed by 36 d on a diet replacing 6.5% total E from SFA with MUFA (15.1% E; 14.5% E OA) or PUFA (12.7% E; 12.6% E LA) diets. ↔Lp(a), ↑LDL-C (compared to MUFA diet)
Mensink et al. (1992) [48] Intervention trial 56 total
26 males
30 females
Young (specific ages not stated) 3 weeks SA diet (11.8% E), LA diet (12% E), or TFA diet (7.7% E). ↔Lp(a) (compared to SA diet)
↓Lp(a) (compared to TFA diet)
↓LDL-C
Sola et al. (1997) [42] Randomized
crossover
22 males Mean, 49.7 (SE, ± 0.6 years) 32 weeks Stabilization period for 8 wk, followed by two 8 wk dietary treatments separated by an 8 wk washout period. The dietary treatments included a diet rich in OA (18.2% E MUFA) and one rich in LA (18.1% E PUFA). ↑oxidized HDL3,
↔total C, ↔LDL-C
↔HDL2-C, ↔HDL3-C
↔TG, ↔apoB
↓apoA1, ↓apoA2
Sanders et al. (1997) [35] Randomized
crossover
26 males 18–34 years 17 weeks 3 wk of a SFA diet (16% E SFA; mostly PA and SA), followed by 3 wk of an n-3 diet (1.5% E EPA and DHA or 5 g/d) or an n-6 diet (1.5% E LA or 5 g/d), separated by an 8 wk washout period. ↑TG, ↑HDL3-C, ↑apoA2
↓HDL2-C
(compared with n-3 diet)
↓total C, ↓LDL-C, ↓apoB ↑Lp(a)
(compared with SFA diet)
Pang et al. (1998) [44] Randomized
single-blinded
29 males 18–35 years 8 weeks After a 2 wk stabilization period, the subjects followed either an ALA-rich diet (10.1 g/d, 3.5% E ALA and 12.1 g/d, 3.1% E LA; ALA:LA ratio of 1:0.9) or an LA-rich diet (1 g/d, 0.1% E ALA and 21 g/d, 6.7% E LA; ALA:LA ratio of 1:66) for 6 wk. ↔total C, ↔LDL-C ↔HDL-C, ↔HDL2-C
↔HDL3-C, ↔TG
Wagner et al. (2001) [36] Randomized
double-blinded crossover
28 males 19–31 years mean, 23.7 years 11 weeks After 2 wk of adjustment, the subjects consumed 80 g/d PUFA-rich corn oil (11.3% E LA and 9.6% E OA) or 80 g of a MUFA-rich mixture of olive and sunflower oils (5.7% E LA and 13.6% E OA) for 2 wk. ↓total C
(after crossover; compared with MUFA-rich mixture)
↓LDL-C, ↓TG, ↓VLDL-TG
↓VLDL-C
(after initial 2 wk)
↔HDL-C
French et al. (2002) [38] Intervention trial 3 males
3 females
Mean, 25 years 8 months The subjects consumed 8 different diets for 21 d each, with a break of 7 d between diets. The diets provided 10% E PA, with levels of LA starting at 10% E and gradually decreasing to 2.5% E. ↓total C, ↓LDL-C
(from 4.5% E to 10% E LA; 10% E LA produced the lowest LDL-C)
↓HDL-C
(from 2.5% E to 10% E LA; 2.5% E LA produced the highest HDL-C)
Goyens et al. (2005) [40] Randomized double-blinded 21 males
33 females
Males: mean, 52.6 years (SD, ± 13.7)
Females: mean, 47.7 years (SD, ± 11.1)
10 weeks Following a 4 wk run-in period, 18 subjects per group consumed a control diet (7% E LA and 0.4% E ALA, ALA:LA ratio of 1:19), low-LA diet (3% E LA, 0.4% ALA) or high-ALA (7% E LA, 1.1% E ALA). Both treatment diets had an ALA:LA ratio of 1:7. ↓total C,↓LDL-C, ↓apoB
↓total:HDL cholesterol ratio
(High-ALA group compared with control)
↔HDL-C, ↔apoA1
↔TG
(all groups)
↓medium VLDL
(Low-LA group compared with control)
↓small VLDL
(High-ALA group compared with control)
Thijssen et al. (2005) [43] Randomized crossover 18 males
27 females
28-66 years mean, 51 years
(SD, ± 10)
17 weeks Each participant consumed each diet for 5 wk, with a washout period of ≥ 1 wk. The diets did not differ, except for the replacement of 7% E with SA, OA, or LA. ↔total C, ↔LDL-C ↔HDL-C, ↔TG
↔apoA1, ↔apoB
↔total:HDL cholesterol ratio
↔lipoprotein particle sizes
(all diets compared)
Liou et al. (2007) [46] Randomized crossover 22 males 20–45 years
mean, 27.9 years
(SEM, ± 1.1)
10 weeks Following a 2 wk phase without consumption of fish and seafood, each subject consumed the high LA diet (10.5% E LA; LA:ALA ratio of ~10:1) and the low LA diet (3.8% E LA; LA:ALA ratio of ~4:1) for 4 wk each. ALA was maintained at ~1% E for each diet. ↔total C, ↔LDL-C ↔HDL-C
↔LDL:HDL cholesterol ratio, ↔TG
Damsgaard et al. (2008) [45] Randomized
double-blinded
64 males 19–40 years 10 weeks Following a 2 wk run-in period, the participants consumed fish oil capsules (3.1 g/d n-3 LC PUFA; 1.8 g/d EPA, 0.2 g/d DPA, and 1.1 g/d DHA) or olive oil capsules (3.7 g/d OA) for 8 wk. Within each group, the subjects consumed either a low-LA diet (12.7 g LA/100 g fats or 4% E LA) or a high-LA diet (40.3 g LA/100 g fats or 7% E LA; 7.3 g/d higher LA). ↓TG
(fish oil groups compared with olive oil groups; TG decreased by 51% in the low-LA group compared to a decrease of 19% in the high-LA group; not significant)
↔total C, ↔LDL-C ↔HDL-C
van Schalkwijk et al. (2014) [37] Randomized
double-blinded crossover
12 males 30–60 years
mean, 51 years
(SD, ± 7)
12 weeks A supplement spread of 60 g/d MCFA (65% C8:0 and C10:0) or LCFA (71% LA) for 3 wk, with a washout period of 6 wk between treatments. ↓total C, ↓LDL-C
↓VLDL-C, ↓TG
↓LDL-TG, ↓VLDL-TG
Dias et al. (2017) [47] Randomized
Intervention trial
6 males
20 females
18–65 years 6 weeks A SFA-rich diet (18.9% E SFA and 2.9% E LA) or an n-6 PUFA-rich diet (12.6% E SFA and 12.7% E LA) for 6 wk. Each diet was supplemented daily with 400 mg EPA + 2000 mg DHA. ↔total C, ↔VLDL-C
↔LDL-C, ↔ HDL-C
↔VLDL-TG, ↔total TG
(no difference between diets; however, both diets reduced VLDL-C, VLDL-TG and total TG)

Abbreviations: ALA, alpha-linolenic acid; apo, apolipoprotein; C, cholesterol; d, days; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; E, energy; EPA, eicosapentaenoic acid; HDL, high-density lipoprotein; LA, linoleic acid; LCFA, long-chain fatty acid; LDL, low-density lipoprotein; Lp, lipoprotein; MCFA, medium-chain fatty acid; MUFA, monounsaturated fatty acid; OA, oleic acid; PA, palmitic acid; PUFA, polyunsaturated fatty acid; SA, stearic acid; SFA, saturated fatty acid; TFA, trans-fatty acid; TG, triglyceride; VLDL, very-low-density lipoprotein; wk, weeks; ↑, increase; ↓, decrease; ↔, no significant difference between groups.